| 1 |
33868970 | Virtual screening by targeting proteolytic sites of furin and TMPRSS2 to propose potential compounds obstructing the entry of SARS-CoV-2 virus into human host cells. | 2022 Jan |
1 |
| 2 |
35063125 | The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. | 2022 Feb 8 |
1 |
| 3 |
35072549 | The discovery and development of transmembrane serine protease 2 (TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19. | 2022 Mar |
1 |
| 4 |
35215982 | In Silico Analysis and Synthesis of Nafamostat Derivatives and Evaluation of Their Anti-SARS-CoV-2 Activity. | 2022 Feb 14 |
5 |
| 5 |
35294338 | Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry. | 2022 Mar 23 |
1 |
| 6 |
33505639 | Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2. | 2021 |
1 |
| 7 |
33821268 | Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry. | 2021 Jul 30 |
1 |
| 8 |
33996911 | Computational Identification of a Putative Allosteric Binding Pocket in TMPRSS2. | 2021 |
2 |
| 9 |
34075338 | Structural insights and inhibition mechanism of TMPRSS2 by experimentally known inhibitors Camostat mesylate, Nafamostat and Bromhexine hydrochloride to control SARS-coronavirus-2: A molecular modeling approach. | 2021 |
3 |
| 10 |
34100014 | Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease. | 2021 Aug 12 |
2 |
| 11 |
34209110 | Identification of 13 Guanidinobenzoyl- or Aminidinobenzoyl-Containing Drugs to Potentially Inhibit TMPRSS2 for COVID-19 Treatment. | 2021 Jun 30 |
1 |
| 12 |
34340553 | The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19. | 2021 Aug 31 |
1 |
| 13 |
34406858 | Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease. | 2021 Oct 13 |
2 |
| 14 |
34406864 | TMPRSS2 Activates Hemagglutinin-Esterase Glycoprotein of Influenza C Virus. | 2021 Oct 13 |
1 |
| 15 |
34575594 | Co-Spray Dried Nafamostat Mesylate with Lecithin and Mannitol as Respirable Microparticles for Targeted Pulmonary Delivery: Pharmacokinetics and Lung Distribution in Rats. | 2021 Sep 19 |
1 |
| 16 |
34590967 | Identification of potent inhibitors against transmembrane serine protease 2 for developing therapeutics against SARS-CoV-2. | 2021 Sep 30 |
1 |
| 17 |
34787160 | Targeting mechanism for SARS-CoV-2 in silico: interaction and key groups of TMPRSS2 toward four potential drugs. | 2021 Nov 25 |
3 |
| 18 |
32532094 | The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner. | 2020 Jun 10 |
3 |
| 19 |
32824674 | Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer. | 2020 Aug 18 |
1 |
| 20 |
33382023 | Fisetin 8-C-glucoside as entry inhibitor in SARS CoV-2 infection: molecular modelling study. | 2020 Dec 31 |
1 |